Infusions of neuropeptide y into the lateral septum reduce anxiety-related behaviors in the rat

Pharmacology Biochemistry and Behavior

Volumn 99, Issue 4, 2011, Pages 580-590

  Trent, Natalie L ^a   Menard, Janet L ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Animal models of anxiety; Anxiety; Defensive behavior; Elevated plus maze; Lateral septum; Neuropeptide Y; Novelty induced suppression of feeding test; Shock probe burying test

Indexed keywords

N2 DIPHENYLACETYL N (4 UREIDOMETHYLBENZYL)ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; APPETITE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG MECHANISM; HISTOLOGY; IMMUNOREACTIVITY; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; ARGININE; AROUSAL; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; ENVIRONMENT; FEEDING BEHAVIOR; INJECTIONS; MALE; NEUROPEPTIDE Y; RATS; RATS, LONG-EVANS; RECEPTORS, NEUROPEPTIDE Y; SEPTUM OF BRAIN;

ANIMALIA; MAMMALIA; RATTUS;

EID: 79959660028     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.06.009     Document Type: Article

References (70)

1. Y.S. Allen, T.E. Adrian, J.M. Allen, K. Tatemoto, T.J. Crow, and S.R. Bloom Neuropeptide Y distribution in rat brain Science 221 1983 877 879
2. F. Bacchi, A.A. Mathe, P. Jimenez, L. Stasi, R. Arban, and P. Gerrard Aniolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze Peptides 27 2006 3203 3207
3. C.O. Bondi, G. Barrera, M.D.S. Lapiz, T. Bedard, A. Mahan, and D.A. Morilak Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine Prog Neuropsychopharmacol 31 2007 482 495 (Pubitemid 46209446)
4. K.T. Britton, S. Southerland, E. Van Uden, D. Kirby, J. Rivier, and G. Koob Anxiolytic activity of NPY receptor agonists in the conflict test Psychopharmacology 132 1997 6 13 (Pubitemid 27303733)
5. K.T. Britton, Y. Akwa, M.G. Spina, and G.F. Koob Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze Peptides 21 2000 37 44 (Pubitemid 30126040)
6. A.P. Carobrez, and L.J. Bertoglio Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on Neurosci Biobehav Rev 29 2005 1193 1205 (Pubitemid 41446895)
7. B.M. Chronwall, D.A. DiMaggio, V.J. Massari, V.M. Pickel, D.A. Ruggiero, and T.L. O'Donohue The anatomy of neuropeptide-Y-containing neurons in rat brain Neuroscience 15 1985 1159 1181 (Pubitemid 15226674)
8. A. Degroot, S. Kashluba, and D. Treit Septal GABAergic and hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests Pharmacol Biochem Behav 69 2001 391 399 (Pubitemid 32758722)
9. Y. Dumont, A. Fournier, J.A. St-Pierre, and R. Quirion Autoradiographic distribution of [1251][Leu31, Pro34]PYY and [1251]PYYM6 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands Synapse 22 1996 139 158
10. Y. Dumont, P. Bouchard, and R. Quirion Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4 and Y5 receptors in rodents, guinea pigs, and primates brains J Comp Neurol 402 1998 372 384 (Pubitemid 28541685)
11. Y. Dumont, A. Cadieux, H. Doods, A. Fournier, and R. Quirion Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIBO 3304 (Y1) and CGP71683A (Y5) Can J Physiol Pharmacol 78 2000 116 125 (Pubitemid 30140240)
12. 34]hPP Neuropeptides 38 2004 163 174
13. K. Eaton, F.R. Sallee, and R. Sah Relevance of neuropeptide Y (NPY) in psychiatry Curr Top Med Chem 7 2007 1645 1659 (Pubitemid 350131002)
14. H.G. Everts, and J.M. Koolhaas Differential modulation of lateral septal vasopressin receptor blockade in spatial learning, social recognition, and anxiety-related behaviors in rats Behav Brain Res 99 1999 7 16 (Pubitemid 29084522)
15. J.F. Flood, and J.E. Morley Increased food intake by neuropeptide Y is due to an increased motivation to eat Peptides 12 1991 1329 1332
16. R.F. Genn, S.A. Tucci, J.E. Edwards, and S.E. File Dietary restriction and nicotine can reduce anxiety in female rats Neuropsychopharmacology 28 2003 1257 1263 (Pubitemid 41070895)
17. R.F. Genn, S.A. Tucci, A. Thomas, J.E. Edwards, and S.E. File Age-associated sex differences in response to food deprivation in two animal tests of anxiety Neurosci Biobehav Rev 2 2003 155 161 (Pubitemid 36535397)
18. T.S. Gray, and J.E. Morley Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system Life Sci 38 1986 389 401 (Pubitemid 16163417)
19. E.S. Hanson, and M.F. Dallman Neuropeptide Y (NPY) may integrate responses of hypothalamic feeding systems and the hypothalamo-pituitary-adrenal axis J Neuroendocrinol 7 1995 273 279
20. J. Harro CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies Amino Acids 31 2006 215 230 (Pubitemid 44540184)
21. M. Heilig The NPY system in stress, anxiety and depression Neuropeptides 38 2004 213 224 (Pubitemid 39158860)
22. M. Heilig, and R. Murison Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat Regul Pept 19 1987 221 231 (Pubitemid 17154128)
23. M. Heilig, B. Soderpalm, J.A. Engel, and E. Widerlov Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models Psychopharmacology 98 1989 524 529 (Pubitemid 19193902)
24. M. Heilig, S. McLeod, M. Brot, S.C. Heinrichs, F. Menzaghi, and G.F. Koob Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects Neuropsychopharmacology 8 1993 357 363 (Pubitemid 23162961)
25. S.H.C. Hendry, E.G. Jones, J. DeFelipe, D. Schmechel, C. Brandon, and P. Emson Neuropeptide-containing neurons of the cerebral cortex are also GABAergic Proc Natl Acad Sci U S A 81 1984 6526 6530 (Pubitemid 15221867)
26. K. Inoue, E.P. Zorrilla, A. Tabarin, G.R. Valdez, S. Iwasaki, and N. Kiriike Reduction of anxiety after restricted feeding in the rat: implication for eating disorders Biol Psychiatry 55 2004 1075 1081 (Pubitemid 38680559)
27. R. Karlsson, J.S. Choe, H.A. Cameron, A. THorsell, J.N. Crawley, and A. Holmes The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice Psychopharmacology 195 2008 546 557
28. A. Kask, L. Rago, and J. Harro Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats Regul Pept 75-76 1998 255 262 (Pubitemid 28477535)
29. A. Kask, L. Rago, and J. Harro Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats Brain Res 788 1998 345 348 (Pubitemid 28202184)
30. A. Kask, L. Rago, and J. Harro Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226 Br J Pharmacol 124 1998 1507 1515 (Pubitemid 28360575)
31. A. Kask, H.P. Nguyen, R. Pabst, and S. von Horsten Neuropeptide Y Y1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotrophin-releasing hormone- induced anxiety Neuroscience 104 2001 259 283
32. A. Kask, J. Harro, S. von Horsten, J.P. Redrobe, Y. Dumont, and R. Quirion The neurocircuitry and receptor subtypes mediating the anxiolytic-like effects of neuropeptide Y Neurosci Biobehav Rev 26 2002 259 283 (Pubitemid 34555409)
33. P.J. King, P.S. Widdowson, H.N. Doods, and G. Williams Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices J Neurochem 73 1999 641 646 (Pubitemid 29339837)
34. K.E. Kuphal, B. Solway, T. Pedrazzini, and B.K. Taylor Y1 receptor knockout increases nociception and prevents the anti-allodynic actions of NPY Nutrition 24 2008 885 891
35. P.J. Larsen, S.P. Sheikh, C.R. Jakobsen, T.W. Schwa, and J.D. Mikkelsen Regional distribution of putative NPY Y, receptors and neurons expressing Y, mRNA in forebrain areas of the rat central nervous system Eur J Neurosci 5 1993 1622 1637 (Pubitemid 24008949)
36. C. Lever, S. Burton, and J. O'Keefe Rearing on hind legs, environmental novelty, and the hippocampal formation Rev Neurosci 17 2006 111 133
37. J.C. Martel, J.A. St-Pierre, and R. Quirion Neuropeptide Y receptors in rat brain: autoradiographic localization Peptides 7 1986 55 60 (Pubitemid 16082864)
38. J.H. Martin Autoradiographic estimation of the extent of reversible inactivation produced by microinjection of lidocaine and muscimol in the rat Neurosci Lett 127 1991 160 164
39. J. Menard, and D. Treit Lateral and medial septal lesions reduce anxiety in the plus-maze and probe-burying tests Physiol Behav 60 1996 845 853 (Pubitemid 26284287)
40. J. Menard, and D. Treit The septum and the hippocampus differentially mediate anxiolytic effects of R(+)-8-OH-DPAT Behav Pharmacol 9 1998 93 101 (Pubitemid 28186506)
41. J. Menard, and D. Treit Intra-septal infusions of excitatory amino acid receptor antagonists have differential effects in two animal models of anxiety Behav Pharmacol 11 2000 99 108 (Pubitemid 30315844)
42. Z. Merali, C. Levac, and H. Anisman Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice Soc Biol Psych 54 2003 552 565 (Pubitemid 37289442)
43. M. Molina-Hernandez, J.I. Olivera-Lopez, N.P. Tellez-Alcantara, J. Perez-Garcia, and M.T. Jaramillob Estrus variation in anxiolytic-like effects of intra-lateral septal infusions of the neuropeptide Y in Wistar rats in two animal models of anxiety-like behavior Peptides 27 2006 2722 2730 (Pubitemid 44739955)
44. M. Molina-Hernandez, N.P. Tellez-Alcantara, J.I. Olivera-Lopez, and M.T. Jaramillob Antidepressant-like or anxiolytic-like actions of topiramate alone or co-administered with intra-lateral septal infusions of neuropeptide Y in male Wistar rats Peptides 31 2010 1184 1189
45. S.M. Morin, and D.R. Gehlert Distribution of NPY Y5-like immunoreactivity in the rat brain J Mol Neurosci 29 2006 109 114 (Pubitemid 44352534)
46. M. Nakajima, A. Inui, A. Asakawa, K. Momose, N. Ueno, and A. Teranishi Neuropeptide Y produces anxiety via Y2-type receptors Peptides 19 1998 359 363 (Pubitemid 28097936)
47. J.I. Olivera-Lopez, M. Molina-Hernandez, N.P. Tellez-Alcantara, and M.T. Jaramillo Estradiol and neuropeptide Y (intra-lateral septal) reduce anxiety-like behavior in two animal models of anxiety Peptides 29 2008 1396 1403
48. E. Painsipp, T. Wultsch, M.E. Edelsbrunner, R.O. Tasan, N. Singewald, and H. Herzog Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice Genes Brain Behav 7 2008 532 542 (Pubitemid 351991488)
49. M. Pascual, L. Acsady, N. Rocamora, T. Freund, and E. Soriano Expression of neurotrophins in hippocampal interneurons immunoreactive for the neuropeptides somatostatin, neuropeptide- Y, vasoactive intestinal polypeptide and cholecystokinin Neuroscience 89 1999 1089 1101 (Pubitemid 29074628)
50. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 1998 Academic Press New York
51. S. Pellow, P. Chopin, S.E. File, and M. Briley Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J Neurosci Methods 14 1985 149 167 (Pubitemid 16239568)
52. C. Pesold, and D. Treit Excitotoxic lesions of the septum produce anxiolytic effects in the elevated plus-maze and the shock-probe burying tests Physiol Behav 52 1992 37 47
53. C. Pesold, and D. Treit The septum and amygdala differentially mediate the anxiolytic effects of benzodiazepines Brain Res 638 1994 295 301 (Pubitemid 24063317)
54. C. Pesold, and D. Treit The neuroanatomical specificity of the anxiolytic effects of intra-septal infusions of midazolam Brain Res 710 1996 161 168
55. C. Polidori, R. Ciccocioppoa, D. Regolib, and M. Massia Neuropeptide Y receptor(s) mediating feeding in the rat: characterization with antagonists Peptides 21 2000 29 35 (Pubitemid 30126039)
56. P.Y. Risold, and L.W. Swanson Connections of the rat lateral septal complex Brain Res Rev 24 1997 115 195 (Pubitemid 27461311)
57. R.J. Rodgers, and N.J. Johnson Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety Pharmacol Biochem Behav 52 1995 297 303
58. T.J. Sajdyk, M.G. Vandergriff, and D.R. Gehlert Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test Eur J Pharmacol 368 1999 143 147 (Pubitemid 29117135)
59. T.J. Sajdyk, P.L. Johnson, R.J. Leitermann, S.D. Fitz, A. Dietrich, and M. Morin Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal- pituitary axis activity or hyperthermia J Neurosci 28 2008 893 903 (Pubitemid 351159007)
60. T.P. Sheehan, R.A. Chambers, and D.S. Russell Regulation of affect by the lateral septum: implications for neuropsychiatry Brain Res Rev 46 2004 71 117 (Pubitemid 39036164)
61. M.S. Smialowska, J.M. Wieronska, H. Domin, and B. Zieba The effect of intrahippocampal injection of group II and III metabotropic glutamate receptor agonists on anxiety; the role of neuropeptide Y Neuropsychopharmacology 32 2007 1242 1250 (Pubitemid 46788861)
62. G. Sorensen, C. Lindberg, G. Wortwein, T.G. Bolwig, and D.P. Woldbye Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation J Neurosci Res 77 2004 723 729 (Pubitemid 39194614)
63. A. Thorsell, M. Michalkiewicz, Y. Dumont, R. Quirion, L. Caberlotto, and R. Rimondini Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression Proc Natl Acad Sci U S A 97 2000 12852 12857
64. D. Treit, and J. Menard Dissociations among the anxiolytic effects of septal, hippocampal, and amygdaloid lesions Behav Neurosci 111 1997 653 658 (Pubitemid 27251335)
65. D. Treit, J.P.J. Pinel, and H.C. Fibiger Conditioned defensive burying: a new paradigm for the study of anxiolytic agents Pharmacol Biochem Behav 15 1981 619 626 (Pubitemid 11015566)
66. D. Treit, C. Pesold, and S. Rotzinger Dissociating the anti-fear effects of septal and amygdala lesions using two pharmacologically validated models of rat anxiety Behav Neurosci 1117 1993 770 785 (Pubitemid 23339170)
67. N.L. Trent, and J.L. Menard The ventral hippocampus and the lateral septum work in tandem to regulate rats' open arm exploration in the elevated plus-maze Physiol Behav 101 2010 141 152
68. G. Van Dijk, and J.H. Strubbe Time-dependent effects of neuropeptide Y infusion in the paraventricular hypothalamus on ingestive and associated behaviors in rats Physiol Behav 79 2003 575 580 (Pubitemid 37087950)
69. H.A. Wieland, W. Engel, W. Eberlein, K. Rudolf, and H.N. Doods Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents Br J Pharmacol 125 1998 549 555 (Pubitemid 28451494)
70. L. Zaborszky, and A. Duque Local synaptic connections of basal forebrain neurons Behav Brain Res 115 2000 143 1588